Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.

While market timing can be an extremely profitable strategy, it has burned many investors and requires rigorous analysis - something we specialize in at StockStory. Keeping that in mind, here is one stock where the poor sentiment is creating a buying opportunity and two where the outlook is warranted.

Two Stocks to Sell:

SoundHound AI (SOUN)

One-Month Return: -9.7%

Born from the idea that machines should understand human speech as naturally as people do, SoundHound AI (NASDAQ: SOUN) develops voice recognition and conversational intelligence technology that enables businesses to integrate voice assistants into their products and services.

Why Are We Cautious About SOUN?

1. Bad unit economics and steep infrastructure costs are reflected in its gross margin of 42.4%, one of the worst among software companies
2. Competitive market means the company must spend more on sales and marketing to stand out even if the return on investment is low
3. Negative free cash flow raises questions about the return timeline for its investments

SoundHound AI’s stock price of $8.97 implies a valuation ratio of 15.9x forward price-to-sales. Check out our free in-depth research report to learn more about why SOUN doesn’t pass our bar.

Masimo (MASI)

One-Month Return: +27%

Founded in 1989 to solve the "unsolvable problem" of accurate pulse oximetry during patient movement, Masimo (NASDAQ: MASI) develops and manufactures noninvasive patient monitoring technologies, including its breakthrough pulse oximetry systems that accurately measure blood oxygen levels even during patient movement.

Why Are We Wary of MASI?

1. Products and services are facing significant end-market challenges during this cycle as sales have declined by 16.3% annually over the last two years
2. Smaller revenue base of $1.48 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
3. Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions

Masimo is trading at $175.23 per share, or 30.5x forward P/E. Read our free research report to see why you should think twice about including MASI in your portfolio.

One Stock to Buy:

Insulet (PODD)

One-Month Return: -4.8%

Revolutionizing diabetes care with its tubeless "Pod" technology, Insulet (NASDAQ: PODD) develops and manufactures innovative insulin delivery systems for people with diabetes, primarily through its Omnipod product line.

Why Do We Love PODD?

1. Average constant currency growth of 25.9% over the past two years demonstrates its ability to grow internationally despite currency fluctuations
2. Free cash flow margin jumped by 30.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
3. Improving returns on capital reflect management’s ability to monetize investments

At $252.17 per share, Insulet trades at 39.1x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Stocks We Like Even More

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.